207 related articles for article (PubMed ID: 21301819)
1. Effect of a novel histamine subtype-3 receptor inverse agonist and modafinil on EEG power spectra during sleep deprivation and recovery sleep in male volunteers.
James LM; Iannone R; Palcza J; Renger JJ; Calder N; Cerchio K; Gottesdiener K; Hargreaves R; Murphy MG; Boyle J; Dijk DJ
Psychopharmacology (Berl); 2011 Jun; 215(4):643-53. PubMed ID: 21301819
[TBL] [Abstract][Full Text] [Related]
2. Acute alertness-promoting effects of a novel histamine subtype-3 receptor inverse agonist in healthy sleep-deprived male volunteers.
Iannone R; Palcza J; Renger JJ; Calder N; Cerchio K; Gottesdiener K; Hargreaves R; Dijk DJ; Boyle J; Murphy MG
Clin Pharmacol Ther; 2010 Dec; 88(6):831-9. PubMed ID: 20981000
[TBL] [Abstract][Full Text] [Related]
3. Alertness and psychomotor performance effects of the histamine-3 inverse agonist MK-0249 in obstructive sleep apnea patients on continuous positive airway pressure therapy with excessive daytime sleepiness: a randomized adaptive crossover study.
Herring WJ; Liu K; Hutzelmann J; Snavely D; Snyder E; Ceesay P; Lines C; Michelson D; Roth T
Sleep Med; 2013 Oct; 14(10):955-63. PubMed ID: 23920422
[TBL] [Abstract][Full Text] [Related]
4. Effects of modafinil on the sleep EEG depend on Val158Met genotype of COMT.
Bodenmann S; Landolt HP
Sleep; 2010 Aug; 33(8):1027-35. PubMed ID: 20815183
[TBL] [Abstract][Full Text] [Related]
5. The brain H3-receptor as a novel therapeutic target for vigilance and sleep-wake disorders.
Parmentier R; Anaclet C; Guhennec C; Brousseau E; Bricout D; Giboulot T; Bozyczko-Coyne D; Spiegel K; Ohtsu H; Williams M; Lin JS
Biochem Pharmacol; 2007 Apr; 73(8):1157-71. PubMed ID: 17288995
[TBL] [Abstract][Full Text] [Related]
6. Modafinil Increases Awake EEG Activation and Improves Performance in Obstructive Sleep Apnea during Continuous Positive Airway Pressure Withdrawal.
Wang D; Bai XX; Williams SC; Hua SC; Kim JW; Marshall NS; D'Rozario A; Grunstein RR
Sleep; 2015 Aug; 38(8):1297-303. PubMed ID: 26158894
[TBL] [Abstract][Full Text] [Related]
7. Distinctive effects of modafinil and d-amphetamine on the homeostatic and circadian modulation of the human waking EEG.
Chapotot F; Pigeau R; Canini F; Bourdon L; Buguet A
Psychopharmacology (Berl); 2003 Mar; 166(2):127-38. PubMed ID: 12552359
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of acute and repeat dosing with the H3 antagonist GSK189254 on the sleep-wake cycle and narcoleptic episodes in Ox-/- mice.
Guo RX; Anaclet C; Roberts JC; Parmentier R; Zhang M; Guidon G; Buda C; Sastre JP; Feng JQ; Franco P; Brown SH; Upton N; Medhurst AD; Lin JS
Br J Pharmacol; 2009 May; 157(1):104-17. PubMed ID: 19413575
[TBL] [Abstract][Full Text] [Related]
9. Early-stage comparative effectiveness: randomized controlled trial with histamine inverse agonist MK-7288 in excessive daytime sleepiness patients.
Sun H; MacLeod C; Mostoller K; Mahon C; Han L; Renger JJ; Ma J; Brown KR; Schulz V; Kay GG; Herring WJ; Lines C; Rosen LB; Murphy MG; Wagner JA
J Clin Pharmacol; 2013 Dec; 53(12):1294-302. PubMed ID: 24122944
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms of ADORA2A modulate psychomotor vigilance and the effects of caffeine on neurobehavioural performance and sleep EEG after sleep deprivation.
Bodenmann S; Hohoff C; Freitag C; Deckert J; Rétey JV; Bachmann V; Landolt HP
Br J Pharmacol; 2012 Mar; 165(6):1904-1913. PubMed ID: 21950736
[TBL] [Abstract][Full Text] [Related]
11. 3-(1'-Cyclobutylspiro[4H-1,3-benzodioxine-2,4'-piperidine]-6-yl)-5,5-dimethyl-1,4-dihydropyridazin-6-one (CEP-32215), a new wake-promoting histamine H3 antagonist/inverse agonist.
Hudkins RL; Gruner JA; Raddatz R; Mathiasen JR; Aimone LD; Marino MJ; Bacon ER; Williams M; Ator MA
Neuropharmacology; 2016 Jul; 106():37-45. PubMed ID: 26400408
[TBL] [Abstract][Full Text] [Related]
12. Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial.
Dauvilliers Y; Bassetti C; Lammers GJ; Arnulf I; Mayer G; Rodenbeck A; Lehert P; Ding CL; Lecomte JM; Schwartz JC;
Lancet Neurol; 2013 Nov; 12(11):1068-75. PubMed ID: 24107292
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of modafinil and sleep deprivation on sleep and cortical EEG spectra in mice.
Kopp C; Petit JM; Magistretti P; Borbély AA; Tobler I
Neuropharmacology; 2002 Jul; 43(1):110-8. PubMed ID: 12213265
[TBL] [Abstract][Full Text] [Related]
14. Preclinical evaluation of the abuse potential of Pitolisant, a histamine H₃ receptor inverse agonist/antagonist compared with Modafinil.
Uguen M; Perrin D; Belliard S; Ligneau X; Beardsley PM; Lecomte JM; Schwartz JC
Br J Pharmacol; 2013 Jun; 169(3):632-44. PubMed ID: 23472741
[TBL] [Abstract][Full Text] [Related]
15. Modafinil reduces microsleep during partial sleep deprivation in depressed patients.
Beck J; Hemmeter U; Brand S; Muheim F; Hatzinger M; Holsboer-Trachsler E
J Psychiatr Res; 2010 Oct; 44(13):853-64. PubMed ID: 20171656
[TBL] [Abstract][Full Text] [Related]
16. An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin-/- mice and patients.
Lin JS; Dauvilliers Y; Arnulf I; Bastuji H; Anaclet C; Parmentier R; Kocher L; Yanagisawa M; Lehert P; Ligneau X; Perrin D; Robert P; Roux M; Lecomte JM; Schwartz JC
Neurobiol Dis; 2008 Apr; 30(1):74-83. PubMed ID: 18295497
[TBL] [Abstract][Full Text] [Related]
17. Modafinil improves real driving performance in patients with hypersomnia: a randomized double-blind placebo-controlled crossover clinical trial.
Philip P; Chaufton C; Taillard J; Capelli A; Coste O; Léger D; Moore N; Sagaspe P
Sleep; 2014 Mar; 37(3):483-7. PubMed ID: 24587570
[TBL] [Abstract][Full Text] [Related]
18. Wake-Promoting and EEG Spectral Effects of Modafinil After Acute or Chronic Administration in the R6/2 Mouse Model of Huntington's Disease.
Vas S; Casey JM; Schneider WT; Kalmar L; Morton AJ
Neurotherapeutics; 2020 Jul; 17(3):1075-1086. PubMed ID: 32297185
[TBL] [Abstract][Full Text] [Related]
19. Maintaining alertness and performance during sleep deprivation: modafinil versus caffeine.
Wesensten NJ; Belenky G; Kautz MA; Thorne DR; Reichardt RM; Balkin TJ
Psychopharmacology (Berl); 2002 Jan; 159(3):238-47. PubMed ID: 11862356
[TBL] [Abstract][Full Text] [Related]
20. In vivo pharmacological profile of S 38093, a novel histamine H3 receptor inverse agonist.
Panayi F; Sors A; Bert L; Martin B; Rollin-Jego G; Billiras R; Carrié I; Albinet K; Danober L; Rogez N; Thomas JY; Pira L; Bertaina-Anglade V; Lestage P
Eur J Pharmacol; 2017 May; 803():1-10. PubMed ID: 28315340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
